HDAC inhibitor treatment induces a metastatic phenotype in cell lines with p53 gain of function mutations.

被引:0
|
作者
Montgomery, M. R. [1 ]
Hull, E. E. [1 ]
机构
[1] Midwestern Univ, Biomed Sci, Glendale, AZ USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P1920
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53
    E Alli
    J-M Yang
    W N Hait
    Oncogene, 2007, 26 : 1003 - 1012
  • [42] Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53
    Alli, E.
    Yang, J-M
    Hait, W. N.
    ONCOGENE, 2007, 26 (07) : 1003 - 1012
  • [43] p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
    Mrakovcic, Maria
    Kleinheinz, Johannes
    Froehlich, Leopold F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [44] p14/ARF expression and promoter methylation, and p53 mutations in neuroblastoma cell lines
    Blanco, Idoia
    Lazcoz, Paula
    Celay, Jon
    Fan, Xing
    Castresana, Javier
    Encio, Ignacio
    CANCER RESEARCH, 2009, 69
  • [45] The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
    Cadwell, C
    Zambetti, GP
    GENE, 2001, 277 (1-2) : 15 - 30
  • [46] IDENTIFICATION OF RB MUTATIONS AND P53 MUTATIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES
    ZHOU, M
    YEAGER, AM
    GU, L
    FINDLEY, HW
    BLOOD, 1994, 84 (10) : A46 - A46
  • [47] Refolding & restoring function to mutant p53: HDAC inhibitor MS275 partially restores activity to R175H mutant p53
    Baatz, Margaux
    Flores, Brianna
    Moore, Jacob
    Leyva, Kathryn J.
    Hull, Elizabeth E.
    CANCER RESEARCH, 2019, 79 (13)
  • [48] Refolding & Restoring Function to Mutant p53: HDAC Inhibitor MS275 Partially Restores Activity to R175H Mutant p53
    Baatz, M. A.
    Flores, B. M.
    Pascual, A. S.
    Leyva, K. J.
    Hull, E. E.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [49] Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
    Meng, Xiangbing
    Yang, Shujie
    Li, Yujun
    Li, Yiyang
    Devor, Eric J.
    Bi, Jianling
    Wang, Xinhao
    Umesalma, Shaikamjad
    Quelle, Dawn E.
    Thiel, William H.
    Thiel, Kristina W.
    Leslie, Kimberly K.
    DISEASE MARKERS, 2018, 2018
  • [50] Mutant p53 gain-of-function induces HER2 over-expression
    Diaz-Chavez, Jose
    Roman-Rosales, Alejandra
    Garcia-Villa, Enrique
    Gariglio, Patricio
    Herrera, Luis A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S44 - S44